supp.fit

Inositol and Folic Acid: study protocols

37 study groups took Inositol together with Folic Acid. These are the doses the studies gave. They are not a recommendation.

Inositol: what the research found →

Dose per serving from research: Inositol

37 study groups in 33 studies say how much Inositol participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 2.5 g to 5 g, 76% of 37 study groups.

Daily doseStudy groups
500 mg or less
1
500 mg to 1 g
3
1 g to 2.5 g
5
2.5 g to 5 g
28

Dose per serving from research: Folic Acid

36 study groups in 32 studies say how much Folic Acid participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 250 mcg to 500 mcg, 78% of 36 study groups.

Daily doseStudy groups
250 mcg or less
2
250 mcg to 500 mcg
28
500 mcg to 1 mg
1
1 mg to 2.5 mg
2
2.5 mg to 5 mg
1
5 mg to 10 mg
0
10 mg to 25 mg
0
25 mg to 50 mg
0
50 mg to 100 mg
0
over 100 mg
2

Commonly used together

8 of 37 study groups took Inositol and Folic Acid with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Vitamin D
6
Calcium
5
Iodine
5
Iron
5
Probiotics
5
Riboflavin
5
Vitamin B12
5
Vitamin B6
5
Zinc
5
β-carotene
4

37 study groups

Study
The effect of myo-inositol supplementation on the prevention of gestational diabetes in overweight pregnant women: a randomized, double-blind, controlled trial
2023 · myo-inositol group · Overweight pregnant women at 12–14 weeks of gestation
2 g400 mcg10 weeks—
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial
2015 · myo-inositol · Pregnant obese women (prepregnancy BMI 30 or greater)
4 g400 mcg—110
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial
2016 · myo-inositol group · Pregnant overweight, non-obese women with pre-pregnancy BMI ≥25 and <30 kg/m²
4 g400 mcg—110
Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: an open-label, randomized controlled trial
2024 · MI group · Pregnant women at 11–13+6 weeks of gestation
4 g400 mcg—100
Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women
2010 · MYO plus folic acid, with r-FSH added if no pregnancy occurred · Women with polycystic ovary syndrome, menstrual irregularities, chronic anovulation, and female infertility; ages not reported
4 g400 mcg—60
myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study
2013 · myo-inositol group · Pregnant women recruited at 12–13 weeks’ gestation with a first-degree relative with type 2 diabetes, prepregnancy BMI <30 kg/m², and no pregestational diabetes or PCOS
4 g400 mcg——
Higher Plasma Myo-Inositol in Pregnancy Associated with Reduced Postpartum Blood Loss: Secondary Analyses of the NiPPeR Trial
2024 · intervention supplement · Women aged 18–38 years planning conception; those included in this analysis conceived and had a singleton live birth
4 g——293
The effect of myo-inositol, vitamin D3 and melatonin on the oocyte quality and pregnancy in in vitro fertilization: a randomized prospective controlled trial
2020 · Study group · Women undergoing ICSI
3.2 g600 mcg26 weeks50
Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS
2007 · myo-inositol plus folic acid · Women with oligomenorrhea and polycystic ovaries
4 g400 mcg14 weeks45
[Diet, metformin and inositol in overweight and obese women with polycystic ovary syndrome: effects on body composition]
2012 · diet, metformin and MYO (D+M+I) · Overweight or obese women with polycystic ovary syndrome; age not reported
4 g400 mcg90 days9
Myoinositol/folic acid combination for the treatment of erectile dysfunction in type 2 diabetes men: a double-blind, randomized, placebo-controlled study
2006 · myoinositol/folic acid combination · men with type 2 diabetes and erectile dysfunction
4 g400 mcg——
Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial
2011 · Group A · Women with polycystic ovary syndrome undergoing IVF
4 g400 mcg90 days—
The myo-inositol effect on the oocyte quality and fertilization rate among women with polycystic ovary syndrome undergoing assisted reproductive technology cycles: a randomized clinical trial
2019 · study group · infertile women with PCOS undergoing assisted reproductive technology cycles; age not reported
4 g400 mg30 days—
The impact of myo-inositol supplementation on sleep quality in pregnant women: a randomized, double-blind, placebo-controlled study
2022 · myo-inositol supplementation · Pregnant women with low-risk singleton pregnancies, at least 14 weeks’ gestation
2 g200 mcg10 weeks—
Improvement in biochemical manifestations of the serum and follicular fluid and ICSI outcomes in PCOS patients with myo-inositol administration: prospective randomized research
2025 · MI group · Infertile women with PCOS undergoing ovulation induction for ICSI; age not reported
4 g2 mg6 weeks—
A pilot study of D-chiro-inositol plus folic acid in overweight patients with type 1 diabetes
2017 · treated group · Overweight or obese patients with type 1 diabetes receiving intensive insulin therapy
1 g400 mcg24 weeks—
Impact of preconception and antenatal supplementation with myo-inositol, probiotics, and micronutrients on offspring BMI and weight gain over the first 2 years
2024 · Intervention group · Offspring of women aged 18–38 years recruited while planning pregnancy; mothers received the supplement before conception and during pregnancy
4 g400 mcg—287
Infant body composition in a randomised trial of a maternal nutritional supplement during preconception and pregnancy
2025 · Intervention · Women receiving the NiPPeR preconception and pregnancy intervention; offspring were followed during the first two years of life
4 g400 mcg—268
Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial
2018 · DCI treatment · Pregnant women with gestational diabetes mellitus
500 mg400 mcg8 weeks20
Myo-inositol nutritional supplement for prevention of gestational diabetes (EMmY): a randomised, placebo-controlled, double-blind pilot trial with nested qualitative study
2022 · intervention (myo-inositol) · Pregnant women aged at least 16 years with a singleton pregnancy at 12+0 to 15+6 weeks’ gestation and high risk of gestational diabetes
4 g400 mcg—99
Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS
2014 · D-chiro-inositol group · Women with PCOS and menstrual irregularities
1 g400 mcg26 weeks25
Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: Prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial
2023 · intervention · Women planning pregnancy; generally healthy, recruited before conception
4 g400 mcg—870
Myoinositol plus α-lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study
2021 · Treated group · Women aged 18–44 with gestational diabetes mellitus and a singleton pregnancy
4 g400 mcg60 days60
Effect of myo-inositol supplementation on ICSI outcomes among poor ovarian responder patients: A randomized controlled trial
2020 · Group A · Poor responder patients undergoing ICSI; age and sex details not reported
4 g400 mcg—56
Inositol for the prevention of neural tube defects: a pilot randomised controlled trial
2016 · inositol+FA group · Women aged 18–40 planning pregnancy, with a history of a previous neural tube defect-affected pregnancy
1 g5 mg—25
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes
2011 · study group · Women with gestational diabetes treated with diet
4 g400 mcg8 weeks24
Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial
2018 · MI treatment · Pregnant women with gestational diabetes mellitus
4 g400 mcg8 weeks20
Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial
2018 · MI plus DCI treatment · Pregnant women with gestational diabetes mellitus
1.13 g400 mcg8 weeks20
Effect of Myo-Inositol Treatment on Serum Asprosin Levels of Pregnant Women: A Prospective Randomized Controlled Pilot Study
2025 · Group 1 · Pregnant women aged 18–40 without the stated exclusion conditions
4 g400 mcg21 weeks20
Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome
2008 · Group A · Overweight patients with polycystic ovary syndrome; age and sex details not stated
2 g200 mcg12 weeks10
Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study
2013 · Group A · Overweight patients with polycystic ovary syndrome; age and sex not specified
2 g200 mg12 weeks10
Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome
2016 · Group A · Women of reproductive age with polycystic ovarian syndrome undergoing IVF
4 g400 mcg——
Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome
2016 · Group B · Women of reproductive age with polycystic ovarian syndrome undergoing IVF
4 g400 mcg——
The ameliorative effect of myo-inositol on apoptosis-related genes expression in cumulus cells of women with polycystic ovary syndrome undergoing ICSI and its relationship with the quality of oocyte and embryo
2025 · MYO group · Infertile women with PCOS undergoing ICSI; age range and sex beyond women not reported
4 g2 mg6 weeks—
Myo-Inositol, Probiotics, and Micronutrient Supplementation From Preconception for Glycemia in Pregnancy: NiPPeR International Multicenter Double-Blind Randomized Controlled Trial
2021 · Intervention · Women aged 18–38 planning to conceive within 6 months; recruited primarily from the community and followed through pregnancy.
4 g400 mcg—870
Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS
2014 · Myo-inositol group · Women with PCOS and menstrual irregularities
4 g400 mcg26 weeks25
The effectiveness of inositol and metformin on infertile polycystic ovary syndrome women with resistant to letrozole
2019 · Group III · Infertile women with polycystic ovary syndrome who did not ovulate after letrozole treatment
4 g400 mcg90 days—